Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Outlook Therapeutics (OTLK) over the last 7 years, with Q2 2025 value amounting to -$0.55.

  • Outlook Therapeutics' Debt to Equity changed N/A to -$0.55 in Q2 2025 from the same period last year, while for Jun 2025 it was -$0.55, marking a year-over-year change of. This contributed to the annual value of -$0.42 for FY2019, which is 637959.87% down from last year.
  • According to the latest figures from Q2 2025, Outlook Therapeutics' Debt to Equity is -$0.55.
  • In the past 5 years, Outlook Therapeutics' Debt to Equity registered a high of -$0.55 during Q2 2025, and its lowest value of -$0.65 during Q1 2025.